Skip to main content
. 2022 Jul 27;276(5):846–853. doi: 10.1097/SLA.0000000000005641

FIGURE 1.

FIGURE 1

Comparison of survival data from matched resected and transplanted cohorts. A, OS of resected Bismuth Type IV benchmark cases (solid line) versus transplanted (dashed line) unresectable PHC cases: 5-year survival is 56.3% versus 39.9%, P=0.07. B, Five-year DFS of 50.2% versus 17.4%, P<0.001. C, OS after exclusion of all cases with underlying PSC. D, DFS after exclusion of all cases with underlying PSC.